Brian Chamberlain

Brian Chamberlain has a wealth of experience in the field of medicinal chemistry. Brian currently holds the position of Sr Director, US Head of Medicinal Chemistry and Design at TandemAI since May 2023. Prior to this role, Brian worked as the Director of Medicinal Chemistry at Third Harmonic Bio from November 2021 to May 2023. Before that, they spent several years at the Broad Institute of MIT and Harvard, where they held various positions including Senior Group Leader, Group Leader, and Senior Research Scientist in Medicinal Chemistry from February 2019 to November 2021. Brian also worked at Silicon Therapeutics as a Principal Investigator and Senior Investigator from May 2017 to February 2019. Brian started their career at YUMA THERAPEUTICS CORPORATION as a Senior Scientist in Medicinal Chemistry from June 2015 to May 2017. Brian also gained experience as a Scientist at MAX BioPharma, Inc. and as a Post-Doctoral Researcher at the University of California, Los Angeles, where they conducted research in medicinal chemistry and complex molecule synthesis. Brian began their career as a Lab Technician at Focus Diagnostics. Throughout their career, Brian has played key roles in leading medicinal chemistry projects, managing teams, and contributing to the optimization and discovery of small molecules for various therapeutic purposes.

Brian Chamberlain has an education history that includes attending UCLA for an unknown period of time but with no specified degree or field of study. Brian then went on to pursue a Bachelor's Degree in Biological Sciences with a minor in Cinema-Television at the University of Southern California from 2003 to 2007. After completing their undergraduate studies, Brian pursued a Doctor of Philosophy (Ph.D.) in Chemistry, specifically in the Prof. Charles McKenna Group, at the University of Southern California from 2007 to 2012.